Piper Sandler Cuts Docusign (NASDAQ:DOCU) Price Target to $52.00

Docusign (NASDAQ:DOCUGet Free Report) had its price target reduced by stock analysts at Piper Sandler from $75.00 to $52.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s price objective points to a potential upside of 8.90% from the stock’s current price.

Other research analysts have also recently issued research reports about the stock. Evercore lowered their price target on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating on the stock in a research report on Friday, December 5th. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a report on Tuesday, March 10th. Morgan Stanley cut their price objective on Docusign from $90.00 to $69.00 and set an “equal weight” rating for the company in a research report on Wednesday. Royal Bank Of Canada decreased their price objective on shares of Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday. Finally, Zacks Research downgraded shares of Docusign from a “strong-buy” rating to a “hold” rating in a report on Monday, November 24th. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat, Docusign has a consensus rating of “Hold” and a consensus price target of $67.73.

Check Out Our Latest Stock Report on DOCU

Docusign Stock Up 0.4%

Shares of NASDAQ DOCU traded up $0.21 during midday trading on Wednesday, reaching $47.75. 7,088,167 shares of the stock were exchanged, compared to its average volume of 4,843,658. The firm has a market cap of $9.56 billion, a price-to-earnings ratio of 33.32, a PEG ratio of 2.04 and a beta of 1.03. The firm has a 50-day simple moving average of $51.11 and a two-hundred day simple moving average of $64.46. Docusign has a twelve month low of $40.16 and a twelve month high of $94.67.

Docusign (NASDAQ:DOCUGet Free Report) last posted its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.06. The business had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. Docusign had a net margin of 9.57% and a return on equity of 15.02%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.86 EPS. Research analysts expect that Docusign will post 1.17 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CRO Paula Hansen sold 6,000 shares of the firm’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the sale, the executive directly owned 68,970 shares in the company, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider James P. Shaughnessy sold 12,000 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $67.03, for a total transaction of $804,360.00. Following the transaction, the insider owned 54,550 shares of the company’s stock, valued at approximately $3,656,486.50. The trade was a 18.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 51,477 shares of company stock worth $3,521,607 in the last quarter. Company insiders own 1.66% of the company’s stock.

Hedge Funds Weigh In On Docusign

Several hedge funds have recently made changes to their positions in the company. Central Pacific Bank Trust Division purchased a new stake in shares of Docusign during the fourth quarter worth approximately $25,000. Modus Advisors LLC purchased a new position in Docusign in the 4th quarter valued at $27,000. Torren Management LLC acquired a new position in Docusign in the 4th quarter valued at $28,000. Aventura Private Wealth LLC purchased a new position in Docusign during the 4th quarter worth $30,000. Finally, True Wealth Design LLC lifted its stake in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q4 beat and upbeat guidance — DocuSign reported Q4 adjusted EPS of $1.01 and revenue of $836.9M, topping consensus; management provided a slightly stronger-than-expected near‑term revenue outlook. This is the main catalyst for the intraday uptick. DocuSign Beats Q4
  • Positive Sentiment: $2.0 billion buyback increase — The company expanded its share repurchase program by $2B, a significant capital return action that supports EPS and signals confidence from the board. PR Newswire Release
  • Positive Sentiment: IAM/AI momentum — Management highlighted IAM customers generating >$350M ARR and expanding AI partnerships, which investors view as durable upsell/retention levers beyond e‑signature. Earnings Call Transcript
  • Neutral Sentiment: Longer‑term bull case surfaced in commentary — Some deep-dive pieces argue DOCU is oversold given improving margins and Rule-of-40 progress; useful for patient investors but may be less relevant to near‑term price action. Seeking Alpha Analysis
  • Negative Sentiment: Multiple analyst price‑target cuts — Several firms trimmed targets this morning (RBC to $55, UBS to $54, Robert W. Baird to $55, Wells Fargo to $60, Citizens from $124→$86), reflecting caution on growth/profitability. These downgrades cap upside and explain mixed trader sentiment despite the beat. Benzinga: analyst moves
  • Negative Sentiment: Analysts want faster revenue acceleration — Coverage notes that while execution and AI products look promising, many analysts are waiting for sustained 10%+ revenue growth; that expectation gap is driving the recent target cuts and volatility. MSN Article

Docusign Company Profile

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Articles

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.